Search

Your search keyword '"Karanikas, Georgios"' showing total 396 results

Search Constraints

Start Over You searched for: Author "Karanikas, Georgios" Remove constraint Author: "Karanikas, Georgios"
396 results on '"Karanikas, Georgios"'

Search Results

151. Reliable set-up for in-loop 11C-carboxylations using Grignard reactions for the preparation of [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO.

152. Preparation and First Preclinical Evaluation of [18F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1).

153. Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.

154. Application of image-derived and venous input functions in major depression using [carbonyl-11C]WAY-100635

155. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?

156. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas

157. Radiolabeling of [18F]altanserin — a microfluidic approach

158. [18F]FE@SNAP—A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): Microfluidic and vessel-based approaches

159. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling

160. Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?

161. Differential modulation of the default mode network via serotonin-1A receptors.

162. The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients.

163. Value of follow-up diagnostic radioiodine scans in differentiated thyroid cancer.

164. Effects of short- and long-term TSH suppression on lumbar bone mineral density in both genders using PET/CT.

165. Whole-body metabolic connectivity framework with functional PET.

166. Comparison of cardiac image-derived input functions for quantitative whole body [ 18 F]FDG imaging with arterial blood sampling.

167. Rapid, high-yield enzymatic synthesis of n.c.a. 6-[ 18 F]fluorodopamine (6-[ 18 F]FDA) for in vivo application.

168. Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing's Syndrome.

169. Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [ 11 C]Metoclopramide.

170. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries.

171. The relationship between cholecystokinin secretion and pancreatic [ 11 C]methionine uptake in patients after partial pancreaticoduodenectomy.

172. PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

173. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18 F-FDG-PET/CT and 18 F-NaF-PET/CT.

174. [ 11 C]acetate PET as a tool for diagnosis of liver steatosis.

175. [ 18 F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.

176. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.

177. [ 18 F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [ 18 F]FDG-PET/MRI.

178. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.

179. Clinical Value of 18 F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma.

180. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.

181. Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by 18 F-Fluoride and 18 F-FDG.

182. Presurgical evaluation of pediatric epilepsy patients prior to hemispherotomy: the prognostic value of 18 F-FDG PET.

183. Fever of unknown origin (FUO) revised.

184. Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.

185. Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence.

186. Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.

187. Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.

188. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.

189. Hepatic dysfunction contributes to coagulation disturbances in patients undergoing whole body hyperthermia by use of extracorporeal circulation.

190. ¹¹C-acetate PET/CT imaging: physiologic uptake, variants, and pitfalls.

191. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.

192. Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO.

193. Beta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET.

194. Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1).

195. [¹⁸F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches.

196. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.

197. Cytokine profiling of human peripheral blood CD4+ T lymphocytes reveals a new Th-subpopulation (Th6) characterized by IL-6.

198. T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation.

199. [18F]FETO: metabolic considerations.

200. [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.

Catalog

Books, media, physical & digital resources